Rachel S Britt

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
STUDY OBJECTIVE To assess the impact of empiric Pseudomonas pharmacotherapy on 30-day mortality in hospitalized patients with community-onset pneumonia stratified according to their risk (low, medium, or high) of drug-resistant pathogens. DESIGN Retrospective cohort study. DATA SOURCE Veterans Health Administration database. PATIENTS A total of 50,119(More)
BACKGROUND Ceftaroline fosamil is US Food and Drug Administration-approved for acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia, but it is not known how ceftaroline is being used in real-world settings or how adverse effects (AEs) and mortality compare to clinical trials. OBJECTIVE This study describes(More)
  • 1